Magnum Chemi-Gran Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 21-12-2024
- Paid Up Capital ₹ 5.00 M
as on 21-12-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.55 Cr
as on 21-12-2024
- Revenue -43.36%
(FY 2022)
- Profit -2195.01%
(FY 2022)
- Ebitda -32371.68%
(FY 2022)
- Net Worth -106.84%
(FY 2022)
- Total Assets 141.86%
(FY 2022)
About Magnum Chemi-Gran
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company has closed loans amounting to ₹1.55 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Venkata Puchakayala, Tejash Shah, Chenna Puchakayala, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230TG2005PTC046533
- Company No.
046533
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Magnum Chemi-Gran?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Puchakayala  | Managing Director | 14-Jun-2005 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tejash Shah | Director | 12-Aug-2014 | Current |
| Raheel Shah | Director | 12-Aug-2014 | Current |
| Chenna Puchakayala | Director | 02-May-2012 | Current |
| Aravind Badiger | Director | 12-Aug-2014 | Current |
Financial Performance of Magnum Chemi-Gran.
Magnum Chemi-Gran Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 43.36% decrease. The company also saw a substantial fall in profitability, with a 2195.01% decrease in profit. The company's net worth observed a substantial decline by a decrease of 106.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Magnum Chemi-Gran?
In 2022, Magnum Chemi-Gran had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Spinos Life Science And Research Private LimitedActive 8 years 8 monthsRaheel Shah and Aravind Badiger are mutual person
Bdr Lifesciences Private LimitedActive 31 years 2 monthsTejash Shah and Raheel Shah are mutual person
- Bdr Pharmaceuticals International Private LimitedActive 22 years 2 months
Tejash Shah, Raheel Shah and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 14 Mar 2007 | ₹1.55 Cr | Satisfied |
How Many Employees Work at Magnum Chemi-Gran?
Magnum Chemi-Gran has a workforce of 53 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Magnum Chemi-Gran, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magnum Chemi-Gran's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
